Photo of Mitchell E. Gross, MD

Mitchell E. Gross, MD

Accepting New Patients
12414 Exposition Boulevard
Los Angeles, CA 90064
1986.8 miles away
Medical Groups & Affiliations
Providence Specialty Medical Group
Speaks: English
map

Ellison Clinic at Saint John’s

12414 Exposition Boulevard, Los Angeles, CA 90064

Are you covered?

Check to see if your insurance is covered by this provider.

About Mitchell E. Gross

Dr. Gross is Director of Clinical Research at the Ellison Institute and Associate Professor of Medicine at the Keck School of Medicine at the University of Southern California. As a medical oncologist, his clinical activities are focused on improving the care of prostate cancer patients by incorporating the latest research findings and participating in therapeutic clinical trials if appropriate. In 2021, he was honored to be selected as a “Top Doctor” by Los Angeles Magazine.

Dr. Gross has earned degrees from the University of California, San Diego (B.A.), Baylor College of Medicine in Houston (M.D.), and the University of California, Los Angeles (Ph.D. Molecular Biology). He completed a residency in internal medicine and a fellowship in hematology and medical oncology at the UCLA Center for the Health Sciences.

Medical Education

Baylor College of Medicine
1994

Fellowship

University of California, Los Angeles
Hematology and Medical Oncology
2000

Residency

University of California, Los Angeles
Internal Medicine
1997

Internship

University of California, Los Angeles
1995

Board Certifications
  • American Board of Internal Medicine, Medical Oncology
Ellison Clinic at Saint John’s
12414 Exposition Boulevard
Los Angeles, CA 90064

Medical Groups & Affiliations
Providence Specialty Medical Group

Clinical Interests

  • Abdominal Cancer
  • Abdominal Cancer Chemotherapy
  • Abnormal Urine Cytology
  • Adenocarcinoma Of The Bladder
  • Adjuvant Chemotherapy
  • Adjuvant Chemotherapy
  • Adolescent And Young Adult Cancer (Aya)
  • Adult T Cell Lymphoma
  • Advanced Malignancies
  • Aids Related Malignancies
  • Alk Negative Anaplastic Large Cell Lymphoma
  • Alveolar Soft Part Sarcoma
  • Anal Cancer Chemotherapy
  • Anaplastic Cancer Of Thyroid
  • Anaplastic Meningioma
  • Androgen Deprivation Therapy
  • Anorectal Cancer Chemotherapy
  • Appendiceal Cancer Chemotherapy
  • Aranesp Injection
  • Atypical Meningioma
  • Autoimmune Cytopenia
  • Autoimmune Lymphoproliferative Syndrome (Alps)
  • Biliary Tract Cancer Chemotherapy
  • Bladder Cancer Chemotherapy
  • Bladder Cancer Genomics
  • Blood Cancer Chemotherapy
  • Blood Transfusion Therapy
  • Bone Marrow Fibrosis
  • Brain Cancer Chemotherapy
  • Brain Cancer Genomics
  • Breast Cancer
  • Breast Cancer Chemotherapy
  • Breast Cancer Genetics
  • Breast Cancer Genomics
  • Bronchus Associated Lymphoid Tissue Lymphoma
  • Cancer
  • Cancer Chemotherapy
  • Cancer During Pregnancy
  • Cancer Genomics
  • Cancer Immunotherapy
  • Cancer Of The Joints
  • Cancer Of The Muscles
  • Cancer Pain
  • Cancer Rehabilitation
  • Cancer Related Anxiety Disorder
  • Cancer Related Bereavement Disorder
  • Cancer Related Cognitive Disorder
  • Cancer Related Depression
  • Cancer Related Fatigue
  • Cancer Related Psychiatric Disorder
  • Cancer Related Sexual Concerns
  • Cancer Related Stress Disorder
  • Cancer Risk
  • Cancer Risk Assessment
  • Cancer Survivor
  • Carcinoma Of Unknown Primary
  • Cervical Cancer
  • Cervical Cancer Chemotherapy
  • Cervical Cancer Genomics
  • Chemoradiation
  • Chronic Neutrophilic Leukemia
  • Clear Cell Meningioma
  • Clinical Trials
  • Colon Cancer Chemotherapy
  • Colon Cancer Genomics
  • Colorectal Cancer Chemotherapy
  • Crizotinib
  • Denys Drash Syndrome (Dds)
  • Developmental Therapeutics Management
  • Diaphragm Cancer
  • Diffuse Intrinsic Pontine Glioma (Dipg)
  • Ductal Carcinoma In Situ (Dcis)
  • Ear Canal Cancer
  • Ear Cancer
  • Egfr Mutation
  • Egfr Translocation
  • Electrolyte Abnormalities In Cancer Patients
  • Endocrine Complications Of Cancer Therapy
  • Endometrial Cancer
  • Endometrial Cancer Chemotherapy
  • Endometrial Cancer Genomics
  • Epithelioid Hemangioendothelioma
  • Epithelioid Malignant Peripheral Nerve Sheath Tumor
  • Erlotinib
  • Erythrocytosis
  • Esophageal Cancer
  • Esophageal Cancer Chemotherapy
  • Extranodal Nk T Cell Lymphoma
  • Eye Cancer
  • Eye Cancer Chemotherapy
  • Eyelid Cancer
  • Eyelid Cancer Chemotherapy
  • Face Cancer
  • Fallopian Tube Cancer Chemotherapy
  • Familial Renal Cell Carcinoma
  • Fibrous Meningioma
  • Flt3 Mutation
  • Gallbladder Cancer
  • Gallbladder Cancer Chemotherapy
  • Gallbladder Cancer Genomics
  • Gastroesophageal Junction Cancer
  • Gastrointestinal (Gi) Cancer
  • Gastrointestinal (Gi) Cancer Genomics
  • Genitourinary Cancer Genomics
  • Germinoma
  • Giant Cell Tumor Of The Bone
  • Gleason Score
  • Glottis Cancer
  • Gynecologic (Gyn) Cancer
  • Gynecologic Cancer Genomics
  • Head And Neck Cancer
  • Head And Neck Cancer Chemotherapy
  • Head And Neck Cancer Genomics
  • Head And Neck Tumors
  • Head Cancer
  • Hemolytic Uremic Syndrome
  • Hepatic Artery Infusion Pump
  • Hepatic Artery Infusion Pump Placement
  • Hereditary Kidney Cancer
  • Hereditary Papillary Renal Cell Cancer
  • Hereditary Retinoblastoma
  • High Risk Cancer Surveillance
  • Histiocytic Sarcoma
  • Histiocytoma
  • Hormone Based Chemotherapy
  • Human Epidural Growth Factor 2 Mutation
  • Human Papillomavirus (Hpv) Related Penile Cancer
  • Human T-Cell Lymphotropic Virus Type 1
  • Human T-Cell Lymphotropic Virus Type 2
  • Hyperthermic Intraperitoneal Chemotherapy (Hipec)
  • Hypopharyngeal Cancer Chemotherapy
  • Idh 1 Mutation
  • Immature Teratoma
  • Immunoassay For Tumor Antigen Ca 125
  • Immunoassay For Tumor Antigen Ca 15-3 And Ca 27-29
  • Infantile Myofibroblastic Tumors
  • Intrapleural Chemotherapy
  • Intravesical Chemotherapy
  • Intravesical Therapy
  • Kidney Cancer
  • Lacrimal Gland Cancer
  • Large Cell Cancer Of The Lung
  • Large Cell Neuroendocrine Tumors
  • Laryngeal Cancer Chemotherapy
  • Leukemia Genomics
  • Li Fraumeni Syndrome
  • Liquid Biopsy Testing
  • Liver Cancer Chemotherapy
  • Liver Cancer Genomics
  • Lobular Carcinoma In Situ (Lcis)
  • Long Term Side Effects Of Cancer Treatment
  • Lung Cancer
  • Lung Cancer Genomics
  • Lymphedema Therapy
  • Lymphoma
  • Lymphoma Genomics
  • Lymphoproliferative Disorder
  • Malignant Carcinoid Tumor Of Colon
  • Malignant Lung Tumors
  • Malignant Spindle Cell Neoplasm
  • Mediastinal Lymphadenopathy
  • Melanoma Genomics
  • Melanoma Of The Rectum
  • Melanoma On Foot
  • Melanoma On Leg
  • Melanoma On Toe
  • Melanoma On Trunk
  • Melanoma Surgery
  • Melanotic Schwannoma
  • Meningeal Melanoma
  • Metastatic Liver Cancer
  • Metastatic Rib Cancer
  • Microsatellite Stability
  • Monocytosis
  • Mouth Cancer Chemotherapy
  • Mucosal Melanoma
  • Multi-Cancer Early Detection Blood Test
  • Muscle Invasive Bladder Cancer
  • Musculoskeletal Tumor
  • Myeloproliferative Diseases
  • Nasal Cavity Cancer Chemotherapy
  • Nasopharyngeal Cancer Chemotherapy
  • Neuronal Glial Tumors
  • Nodular Lymphocyte Predominant Hodgkin Lymphoma
  • Non Germinomatous Germ Cell Tumor
  • Non Hodgkin Lymphoma
  • Non Steroidal Aromatase Inhibitors
  • Non-Muscle Invasive Bladder Cancer
  • Octreotide Treatment
  • Onco Nephrology
  • Optic Nerve Glioma
  • Oral Complications Of Cancer
  • Oral Lesions
  • Orbit Cancer
  • Ovarian Cancer Chemotherapy
  • Ovarian Non Germ Cell Tumors
  • Palate Cancer
  • Pancreatic Cancer Chemotherapy
  • Pancreatic Cancer Genomics
  • Paraneoplastic Cerebellar Degeneration (Pcd)
  • Pediatric Cancer Research
  • Penile Cancer Chemotherapy
  • Personal History Of Chemotherapy
  • Personal History Of Radiation Therapy
  • Personalized Cancer Therapy
  • Plasma Cell Dyscrasia
  • Pleomorphic Xanthoastrocytomas
  • Pleural Cancer Chemotherapy
  • Post Radiation Pain
  • Primary Effusion Lymphoma
  • Primary Splenic Lymphoma
  • Prostate Cancer Chemotherapy
  • Prostate Cancer Genomics
  • Pulmonary Metastases
  • Rat Sarcoma Oncogenes Mutation
  • Rectal Cancer Genomics
  • Refractory Anemia With Excess Blasts
  • Refractory Cytopenia
  • Relapsed Hodgkin Lymphoma
  • Relapsed Non Hodgkin Lymphoma
  • Renal Cancer Genomics
  • Renal Cell Carcinoma Immunotherapy
  • Renal Pelvis Carcinoma
  • Renal Sarcoma
  • Retroperitoneal Mass
  • Rib Cancer
  • Salvage Cryotherapy
  • Salvage Prostatectomy
  • Sarcoma Genomics
  • Secondary Cancer Screening
  • Side Effects Of Cancer Treatment
  • Sinus Cancer
  • Skin Cancer
  • Skin Cancer Genomics
  • Skin Cancer Of The Ear
  • Skin Cancer Of The Face
  • Skin Cancer Of The Foot
  • Skin Cancer Of The Hand
  • Skin Cancer Of The Scalp
  • Skin Cancer On Penis
  • Small Cell Lung Cancer Chemotherapy
  • Small Intestine Cancer Chemotherapy
  • Smoldering Multiple Myeloma
  • Solid Tumors
  • Spine Mets
  • Spleen Cancer Chemotherapy
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma Of Bladder
  • Squamous Cell Carcinoma Of Penis
  • Squamous Cell Carcinoma Of The Head And Neck
  • Squamous Cell Carcinoma Of The Tongue
  • Stomach Cancer
  • Stomach Cancer Chemotherapy
  • Stomach Cancer Genomics
  • Stomatitis
  • Supratentorial Primitive Neuroectodermal Tumor
  • Systemic Therapy
  • T Cell Acute Lymphoblastic Leukemia
  • Targeted Molecular Therapy
  • Teratoma With Malignant Transformation
  • Testicular Cancer Chemotherapy
  • Theranostics
  • Thoracic Cancer
  • Throat Cancer Chemotherapy
  • Thyroid Cancer Genomics
  • Tongue Cancer Chemotherapy
  • Total Parenteral Nutrition (Tpn)
  • Tracheal Cancer
  • Tracheal Cancer Chemotherapy
  • Unknown Primary Cancer
  • Uterine Cancer Chemotherapy
  • Vaginal Cancer Chemotherapy
  • Vaginal Melanoma
  • Vocal Cord Cancer
  • Vulvar Cancer Chemotherapy
  • Waldenstrom Macroglobulinemia
  • Wilms Tumor 1 Mutations
  • Xanthogranuloma